Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0004 Transporter Info | ||||
| Gene Name | ABCG2 | ||||
| Transporter Name | Breast cancer resistance protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Naringenin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 1 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 932 | ||||
| Docking Score | -10.842 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C15H12O5 | ||||
| Molecular Weight | 272.25 | ||||
| Canonical SMILES |
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
|
||||
| InChI |
InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2
|
||||
| InChIKey | FTVWIRXFELQLPI-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 1 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Tamarixetin | ||||
| Xenobiotic Type | Natural Product | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5281699 | ||||
| Docking Score | -10.822 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H12O7 | ||||
| Molecular Weight | 316.26 | ||||
| Canonical SMILES |
COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O
|
||||
| InChI |
InChI=1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3
|
||||
| InChIKey | FPLMIPQZHHQWHN-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.9 | Rotatable Bond Count | 2 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Dolutegravir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 54726191 | ||||
| Docking Score | -10.635 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C20H19F2N3O5 | ||||
| Molecular Weight | 419.4 | ||||
| Canonical SMILES |
C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
|
||||
| InChI |
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
|
||||
| InChIKey | RHWKPHLQXYSBKR-BMIGLBTASA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 3 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 8 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.